Steven Cohen's RYTM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 414,210 shares of Rhythm Pharmaceuticals, Inc. (RYTM) worth $45.99 M, representing 0.05% of the portfolio. First purchased in 2017-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RYTM, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 429,420 shares. Largest reduction occurred in Q2 2026, reducing 432,591 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Rhythm Pharmaceuticals (RYTM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rhythm Pharmaceuticals (RYTM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -432,591 | Reduce 51.09% | 414,210 | $111.03 |
| Q1 2026 | +417,381 | Add 97.20% | 846,801 | $86.97 |
| Q4 2025 | +429,420 | New Buy | 429,420 | $107.04 |
| Q3 2025 | -170,832 | Sold Out | 0 | $0.00 |
| Q2 2025 | +106,990 | Add 167.59% | 170,832 | $63.19 |
| Q1 2025 | +63,842 | New Buy | 63,842 | $52.97 |
| Q4 2023 | -4,146 | Sold Out | 0 | $0.00 |
| Q3 2023 | +4,146 | New Buy | 4,146 | $22.92 |
| Q2 2023 | -11,955 | Sold Out | 0 | $0.00 |
| Q1 2023 | +11,955 | New Buy | 11,955 | $17.84 |
| Q2 2018 | -180,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | +100,000 | Add 125.00% | 180,000 | $19.90 |
| Q4 2017 | +80,000 | New Buy | 80,000 | $29.06 |
Steven Cohen's Rhythm Pharmaceuticals Investment FAQs
Steven Cohen first purchased Rhythm Pharmaceuticals, Inc. (RYTM) in Q4 2017, acquiring 80,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Rhythm Pharmaceuticals, Inc. (RYTM) for 13 quarters since Q4 2017.
Steven Cohen's largest addition to Rhythm Pharmaceuticals, Inc. (RYTM) was in Q4 2025, adding 429,420 shares worth $45.97 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 414,210 shares of Rhythm Pharmaceuticals, Inc. (RYTM), valued at approximately $45.99 M.
As of the Q2 2026 filing, Rhythm Pharmaceuticals, Inc. (RYTM) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Rhythm Pharmaceuticals, Inc. (RYTM) was 846,801 shares, as reported at the end of Q1 2026.